Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

NCT02397928

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Antwerp University Hospital, Thoracic Oncology Antwerp, Belgium
  • Goustave Roussy - Cancer Campus Grand Paris Villejuif, France
  • Universitätsklinikum Halle (Saale) Halle, Germany
  • A.S.O. "SS Antonio e Biagio e Cesare Arrigo" Alessandria, Italy
View all 13 locations
View Trial Details
Completed

Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )

NCT02146131

Conditions
Lung Diseases, Lung Neoplasms, Multiple Pulmonary Nodules, +8 more
Locations
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University Saint Louis St Louis, Missouri, United States
View Trial Details
Completed

A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer

NCT02874664

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
View all 15 locations
View Trial Details
Completed

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

NCT00252382

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +11 more
Locations
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
  • Duke Comprehensive Cancer Center, Duke University Durham, North Carolina, United States
  • Sarah Cannon Research Institute, LLC Nashville, Tennessee, United States
View Trial Details
Completed

Long-term Observation PMS for Afatinib

NCT02131259

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Boehringer Ingelheim Investigational Site 145 Adachi Tokyo, Japan
  • Boehringer Ingelheim Investigational Site 429 Aira Kagoshima, Japan
  • Boehringer Ingelheim Investigational Site 64 Aizuwakamatsu Fukushima, Japan
  • Boehringer Ingelheim Investigational Site 44 Akita Akita, Japan
View all 432 locations
View Trial Details
Completed

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

NCT00638937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • The Ottawa Hospital Cancer Centre (Ottawa Health Research Institute) Civic Campus Ottawa, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Department of Oncology Montreal, Quebec, Canada
View Trial Details
Completed

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

NCT01871805

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California Irvine Irvine, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Loma Linda Cancer Center Loma Linda, California, United States
View all 42 locations
View Trial Details
Completed

Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients

NCT03613467

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • China PLA General Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Tongji Hospital Affiliated to Huazhong Technology Hospital Wuhan, Hubei, China
View Trial Details

Related conditions